Last week, the House of Representatives passed three bills containing provisions that would require certain of the financial regulatory agencies to conduct cost-benefit analysis as part of the rulemaking process: the Regulatory Accountability Act of 2017 (H.R. 5), the SEC Regulatory Accountability Act (H.R. 78), and the Commodity End-User Relief Act (H.R. 238).  The scope and cost-benefit analysis standards of each bill vary, and thus we have prepared these slides to compare the three proposals in active consideration, as well as two previous bill proposals that remain relevant and contain similar provisions.

Law clerk Conrad Scott contributed to this post.

If you have any questions regarding the matters covered in this publication, please reach out to any of the lawyers listed below or your usual Davis Polk contact.

This communication, which we believe may be of interest to our clients and friends of the firm, is for general information only. It is not a full analysis of the matters presented and should not be relied upon as legal advice. This may be considered attorney advertising in some jurisdictions. Please refer to the firm's privacy notice for further details.
Copy link to share post